Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States

Abstract Background There are limited data on economic aspects of the genetic variant of chronic obstructive pulmonary disease (COPD) in the context of the more prevalent form of COPD. The objective of this study was to isolate the healthcare resource utilization and economic burden attributable to...

Full description

Bibliographic Details
Main Authors: Jan Sieluk, Julia F. Slejko, Henry Silverman, Eleanor Perfetto, C. Daniel Mullins
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Alpha-1 antitrypsin deficiency
Rare disease
Chronic obstructive pulmonary disease
Cost-of-illness
Economic analysis
Healthcare resource use
Online Access:http://link.springer.com/article/10.1186/s13023-020-01523-4

Internet

http://link.springer.com/article/10.1186/s13023-020-01523-4

Similar Items